Bullock Alex N, Debreczeni Judit E, Fedorov Oleg Y, Nelson Adam, Marsden Brian D, Knapp Stefan
Structural Genomics Consortium (SGC), Botnar Research Centre, Oxford University, Oxford OX3 7LD, UK.
J Med Chem. 2005 Dec 1;48(24):7604-14. doi: 10.1021/jm0504858.
The kinase PIM-1 plays a pivotal role in cytokine signaling and is implicated in the development of a number of tumors. The three-dimensional structure of PIM-1 is characterized by an unique hinge region which lacks a second hydrogen bond donor and makes it particularly important to determine how inhibitors bind to this kinase. We determined the structures of PIM-1 in complex with bisindolylmaleimide (BIM-1) and established the structure-activity relationship (SAR) for this inhibitor class. In addition, we screened a kinase targeted library and identified a number of high affinity inhibitors of PIM-1 such as imidazo[1,2-b]pyridazines, pyrazolo[1,5-a]pyrimidines, and members of the flavonoid family. In this paper we present an initial SAR of the identified scaffolds determined on the basis of a thermostability shift assay, calorimetric binding data, and biochemical assays which may find applications for the treatment of PIM-1 dependent cancer types.
激酶PIM-1在细胞因子信号传导中起关键作用,并与多种肿瘤的发生发展有关。PIM-1的三维结构具有一个独特的铰链区,该区域缺乏第二个氢键供体,因此确定抑制剂如何与该激酶结合尤为重要。我们确定了与双吲哚基马来酰亚胺(BIM-1)复合的PIM-1结构,并建立了该类抑制剂的构效关系(SAR)。此外,我们筛选了一个激酶靶向文库,鉴定出了多种PIM-1的高亲和力抑制剂,如咪唑并[1,2-b]哒嗪、吡唑并[1,5-a]嘧啶以及黄酮类家族成员。在本文中,我们基于热稳定性变化测定、量热结合数据和生化测定,给出了所鉴定支架的初步构效关系,这些结果可能在治疗PIM-1依赖性癌症类型中得到应用。